On the Fibril Elongation Mechanism of the Prion Protein Fragment PrP106-126

نویسندگان

  • Xin Zhao
  • Shuo-Xing Dou
  • Ping Xie
  • Peng-Ye Wang
چکیده

Mouse prion protein PrP106-126 is a peptide corresponding to the residues 107-127 of human prion protein. It has been shown that PrP106-126 can reproduce the main neuropathological features of prionrelated transmissible spongiform encephalopathies and can form amyloid-like fibrils in vitro. The conformational characteristics of PrP106-126 fibril have been investigated by electron microscopy, CD spectroscopy, NMR and molecular dynamics simulations. Recent researches have found out that PrP106-126 in water assumes a stable structure consisting of two parallel β-sheets that are tightly packed against each other. In this work we perform molecular dynamics simulation to reveal the elongation mechanism of PrP106-126 fibril. Influenced by the edge strands of the fibril which already adopt β-sheets conformation, single PrP106-126 peptide forms β-structure and becomes a new element of the fibril. Under acidic condition, single PrP106-126 peptide adopts a much larger variety of conformations than it does under neural condition, which makes a peptide easier to be influenced by the edge strands of the fibril. However, acidic condition dose not largely affect the stability of PrP106-126 peptide fibril. Thus, the speed of fibril elongation can be dramatically increased by lowering the pH value of the solution. The pH value was adjusted by either changing the protonation state of the residues or adding hydronium ions (acidic solution) or hydroxyl ions (alkaline solution). The differences between these two approaches are analyzed here.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.

Prion diseases are a group of infectious and fatal neurodegenerative disorders caused by the conformational conversion of a cellular prion protein (PrP) into its abnormal isoform PrP(Sc). PrP106-126 resembles PrP(Sc) in terms of physicochemical and biological characteristics and is used as a common model for the treatment of prion diseases. Inhibitory effects on fibril formation and neurotoxici...

متن کامل

NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126.

PrP106-126, a peptide corresponding to residues 107-127 of the human prion protein, induces neuronal cell death by apoptosis and causes proliferation and hypertrophy of glia, reproducing the main neuropathological features of prion-related transmissible spongiform encephalopathies, such as bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Although PrP106-126 has been shown to form...

متن کامل

Prion protein fragment 106-126 potentiates catecholamine secretion from PC-12 cells.

The toxic actions of scrapie prion protein (PrP(sc)) are poorly understood. We investigated the ability of the toxic PrP(sc) fragment 106-126 to interfere with evoked catecholamine secretion from PC-12 cells. Prion protein fragment 106-126 (PrP106-126) caused a time- and concentration-dependent augmentation of exocytosis due to the emergence of a Ca(2+) influx pathway resistant to Cd(2+) but se...

متن کامل

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein

In prion disease, a profound microglial activation that precedes neurodegeneration has been observed in the CNS. It is still not fully elucidated whether microglial activation has beneficial effects in terms of prion clearance or whether microglial cells have a mainly detrimental function through the release of pro-inflammatory cytokines. To date, no disease-modifying therapy exists. Several im...

متن کامل

Structural Diversity and Initial Oligomerization of PrP106–126 Studied by Replica-Exchange and Conventional Molecular Dynamics Simulations

Prion diseases are marked by cerebral accumulation of the abnormal isoform of the prion protein. A fragment of prion protein composed of residues 106-126 (PrP106-126) exhibits similar properties to full length prion and plays a key role in the conformational conversion from cellular prion to its pathogenic pattern. Soluble oligomers of PrP106-126 have been proposed to be responsible for neuroto...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005